中医药对冠心病PCI术后再狭窄炎症反应因子研究进展
중의약대관심병PCI술후재협착염증반응인자연구진전
Research progress of the action of TCM medicine on inflammatory response factor of coronary heart disease after PCI
  • 万方数据
    中医临床研究 중의림상연구
    CLINICAL JOURNAL OF CHINESE MEDICINE
    2014年 1期 138-140 ,共3页

    商晓明%曾庆明%江龙凤%王辉

    상효명%증경명%강룡봉%왕휘

    中医药%冠心病%PCI%再狭窄%炎症反应因子 中醫藥%冠心病%PCI%再狹窄%炎癥反應因子
    중의약%관심병%PCI%재협착%염증반응인자
    TCM medicine%Coronary heart disease%PCI%Restenosis%Inflammatory response factor
    冠心病介入治疗（PCI）已广泛应用于临床，术中造成的局部损伤导致血管内膜发生慢性炎症反应，这一慢性炎症反应与PCI术后再狭窄及心血管事件发生密切相关，研究发现中医药可起到防治冠心病PCI术后再狭窄的作用。
    관심병개입치료（PCI）이엄범응용우림상，술중조성적국부손상도치혈관내막발생만성염증반응，저일만성염증반응여PCI술후재협착급심혈관사건발생밀절상관，연구발현중의약가기도방치관심병PCI술후재협착적작용。
    Percutaneous coronary intervention (PCI) has been widely used in clinical, intraoperative local damage caused chronic inflammation of intimal, this chronic inflammatory response is closely related to restenosis after PCI and cardiovascular events. Medicine research found that TCM medicine can play a role in prevention and treatment of coronary heart disease restenosis after PCI.
    원문보기 원문다운로드 사이트로이동
저자의 최근 논문